[The adjuvant chemotherapy of N(-) patients with breast cancer--when is it indicated?].
The object of this research is determination the necessity of leading of adjuvant chemotherapy with patients with breast cancer without metastases in axillary lymph nodes (N(-)), with disadvantages other prognostic factors (T > 20 mm, estrogen receptors (-), II and III stage grading). Post-operative with 52 women with high risk of recedives or metastases had been performed polychemotherapy (39-CMF and 13 FEC). Control group include 40 patients without adjuvant chemotherapy. Relapse are report with 6 of investigate and 8 of control group (pt > 0.05). The obtained results are discussed in connection with literature data.
Deliĭski
T
T
Baĭchev
G
G
Davidov
D
D
Gorchev
G
G
Velkova
A
A
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D011379:Prognosis; D011446:Prospective Studies; D012307:Risk Factors
Adiuvantna khimioterapiia pri N(-) patsientki s rak na mlechnata zhleza--koga e inditsirana?